Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00427_DB00950_nanopub.RAzbnhPlP0jQW-7-FJuWR6sp5r_XKHN8Xdik_oHXOUxl0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00427_DB00950 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00427_DB00950 label "DDI between Triprolidine and Fexofenadine - Triprolidine and Fexofenadine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects. [drugbank_resource:DB00427_DB00950]" assertion.
- drugbank_resource:DB00427_DB00950 identifier "drugbank_resource:DB00427_DB00950" assertion.
- drugbank_resource:DB00427_DB00950 title "DDI between Triprolidine and Fexofenadine - Triprolidine and Fexofenadine, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Additive CNS depressant effects may also occur. Monitor for enhanced anticholinergic and CNS depressant effects." assertion.
- drugbank:DB00950 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00950 assertion.
- drugbank:DB00427 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00427_DB00950 assertion.